T-cell-activating protein (TAP) is an allelic 12-kDa membrane protein that participates in T-cell activation. Soluble anti-TAP monoclonal antibodies can trigger antigen-specific, major histocompatibility complex-restricted T-cell hybridomas to produce interleukin 2 and are mitogenic for normal T cells and thymocytes. TAP is expressed on 10% of thymocytes, which are mainly cortisone-resistant and mature. In the periphery, TAP is expressed on 70% of resting T cells but not on resting B cells. 
Many murine T-cell surface proteins have been described. These antigens are useful in the dissection of T-cell heterogeneity and in the analysis of T-cell activation. The major T-lymphocyte subsets of helper, cytotoxic, and suppressor cells can be defined on the basis of cell surface phenotype (1) . In the periphery, L3T4 and Lyt-2 expression appears to be mutually exclusive. In general, L3T4 is expressed on helper T cells, whereas Lyt-2 is expressed on cytolytic T cells (CTLs) and suppressor T cells (2) . Markers that detect additional heterogeneity within these compartments are not available but would be useful.
The differential expression of cell surface molecules has been found to reflect the underlying molecular physiology. Thus, L3T4 and Lyt-2 appear to correlate with the class of major histocompatibility complex (MHC) molecules that lymphocytes recognize, which may reflect their interaction with these structures (3) (4) (5) . Several molecules are involved in T-cell activation and do not appear to be subset-restricted. These include T-cell-receptor a and p chains and associated T3 proteins (6, 7) . Crosslinking of Thy-1 leads to T-cell activation; however, the precise physiological role of this molecule is unknown (8) .
Through the use of monoclonal antibodies (mAbs), we have recently identified a T-cell-activating protein, TAP (9) . TAP is an allelic membrane protein of apparent molecular mass 10-12 kDa under nonreducing conditions and 15-17 kDa under reducing conditions (27) . Soluble mAbs directed against this molecule can trigger antigen-specific, MHCrestricted T-cell hybridomas to produce interleukin 2 (IL-2). In addition, anti-TAP mAbs are mitogenic for normal peripheral T cells and thymocytes. Although the TAP molecule appears to be involved in T-cell activation, it is not expressed on all T cells. TAP is expressed on a small subset (10%) of thymocytes that are mainly cortisone-resistant and mature (10) . Cortical thymocytes, which comprise the majority of thymocytes, do not express this determinant. In fact, expression of TAP correlates with the acquisition of immunocompetence and could be involved in the maturation process (10) . Furthermore, TAP is present on a majority of, but not all, resting peripheral T cells. Given that TAP molecules are differentially expressed on lymphocytes, it is of interest to define which cells express this marker. The analysis of the expression of the TAP molecules in distinct lymphocyte subsets and during lymphocyte activation is the subject of this report.
MATERIALS AND METHODS
Mice. C57BL/6 (B6) and BiO.D2 mice 5-7 weeks old were purchased from The Jackson Laboratories. BALB/c mice were purchased from Charles River Breeding Laboratories.
Monoclonal Antibodies. The mAbs used in this work are listed below along with their specificities and references: M5/49, anti-Thy-1 (28); GK1.5, anti-L3T4 (2); ADH4, antiLyt-2.2 (11); 53.6.72, anti-Lyt-2 (12); 1E7 and 3A7, anti-TAP (9) . mAb-containing culture supernatants were prepared as described (13) .
Immunofluorescence. Indirect immunofluorescence was performed as described (9 was for 30 min, except for the phycoerythrin-avidin incubation, which was for 15 min. Two-color analysis was performed on an Epics V cell sorter (Coulter).
Cell Preparation. Whole spleen cells were depleted of erythrocytes by treatment with Tris/NH4Cl buffer. T cells were enriched by passage over nylon wool as described (14) . Negative selection of whole spleen cells or in vitro-activated CTLs was achieved by incubation of 108 cells with 1 ml of hybridoma culture supernatant on ice for 30 min, followed by complement-mediated cytolysis at 370C. Splenic B cells were obtained by anti-Lyt-2/anti-L3T4-plus-complement treatment. Cells were further purified on a Ficoll-Hypaque gradient before use. Con A-or lipopolysaccharide (LPS)-stimulated lymphoblasts were prepared as described (9) . Spleen cells were conjugated with 2,4,6-trinitrophenyl (Tnp) as described (15) . The culture conditions used to generate CTLs have been described in detail (16). 5"Cr-release assays were done as described (15, 16) .
Immunoprecipitation. Membrane proteins were iodinated in lactoperoxidase-catalyzed reactions (17) , using the equivalent of 108 cells and 2 mCi (1 Ci = 37 GBq) of Na'251 in each iodination mixture. Metabolic labeling was achieved by incubatioh of cells with [35S]cysteine as described (9) . Cells were lysed with 1% Nonidet P-40. Immunoprecipitations of antigens were then performed as described (9) .
Electrophoresis and Fluorography. Immunoprecipitates were analyzed by one-dimensional NaDodSO4/polyacrylamide gel electrophoresis as described by Thomas and Kornberg (18) . Gels were incubated with Enlightning (New England Nuclear) and dried. Fluorograms were exposed with an intensifying screen at -70'C.
T-Cell Clones. Clones 5M/B10-75, F1/5R, and LPA/2R were kindly provided by D. Roopenian (The Jackson Laboratory) (19) . They were stimulated with irradiated B10 spleen cells once per week and cultured as described (9) in RPMI 1640 medium (Irvine Scientific) supplemented with 10% culture supernatant from Con A-stimulated rat splenocytes (Con A supernatant). CTL clone DFL12 was kindly provided by D. Ucker (Dana Farber Cancer Institute) (20) . This CTL clone is stimulator-independent and IL-2-dependent and is passaged in RPMI 1640 medium supplemented with 10% Con A supernatant.
RESULTS
Expression of TAP on Peripheral T Cells. We have shown that TAP is expressed on a majority of, but not all, peripheral T cells (9) . To determine the precise distribution of TAP' (Fig. 1C) . In contrast, only 50% of the Lyt-2+ cells are TAP' (Fig. 1D ). Negative selection of peripheral T cells (by treatment with anti-Lyt-2 or anti-L3T4 mAb plus complement) followed by staining for TAP expression gave similar results (data not shown). In the above experiment, the staining is specific, as it is not observed on (Fig. 2) . These TAP+ T cells are made up of both Lyt-2+ and L3T4+ cells (data not shown). In addition to the rapid induction of TAP expression, there is also a marked increase in the intensity of fluorescence staining on a log scale. The magnitude ofthis effect is unlikely to reflect solely an increase in cell size but also an increase in antigen density. The pattern of staining is specific, as it is not observed on Con A blasts from genetically negative strains or with second-step reagents alone (data not shown).
We have previously shown, by standard immunofluorescence techniques, that resting B cells do not express TAP (9) . In view of the inducibility of TAP in T cells, we sought to determine the expression of TAP on activated B cells. Purified B cells were prepared by treatment with anti-L3T4 and anti-Lyt-2 plus complement treatment. By immunofluorescence study, the population so obtained contains less than 1% T cells. These resting B cells are TAP- (Fig. 3) . However, when these cells are stimulated with LPS, they begin to express TAP within 24 hr. By 48 hr, most of the LPS blasts become TAP'. These cells are virtually 100% surface Ig+, Ia+, and Thy-I-, indicating that these blasts are B lymphocytes as expected. This pattern is specific, as LPS blasts from genetically negative strains remain TAP-(data not shown).
To confirm that B lymphocytes synthesize TAP and to compare the TAP molecules on T and B cells, LPS and Con A blasts were surface-labeled with 1251 or labeled metabolically with [35S]cysteine, and TAP was immunoprecipitated (Fig. 4) . TAP on B cells appears to be indistinguishable from TAP on T cells with respect to its migration pattern in NaDodSO4/polyacrylamide gels, although lower amounts of TAP were recovered from LPS blasts. Thus, TAP is synthesized by B cells, and B-cell TAP appears to be identical to that on T cells.
DISCUSSION
TAP is an activating protein, distinct from the T-cell antigen receptor or T3, that we detected initially on antigen-specific, MHC-restricted T-cell hybridomas (9) . It is expressed on 70% of resting T cells but not on resting B cells. In this report, we analyze the expression of TAP on T-cell subsets and activated lymphocytes. [3V5]cysteine (Right). Cell lysis and immunoprecipitation were performed as described (9) with preformed complexes of mAb 3A7 (anti-TAP). Samples were electrophoresed in NaDodSO4/18% polyacrylamide gels after reduction with 2-mercaptoethanol. The TAP bands (arrows) are specific, as they are not observed in immunoprecipitations using nonimmune mouse serum or irrelevant antibodies or in TAP immunoprecipitates from genetically negative strains (BALB/c or C3H) (unpublished observations). Molecular masses of standards run in parallel are shown in kDa.
Many surface proteins have been described on murine lymphocytes. They can be grouped into two broad categories. Members of the first category are lineage-or subsetspecific, such as the T-cell antigen receptor, surface immu--noglobulin, Lyt-2, and L3T4 (3, 4, 6 It is important to relate the pattern of TAP expression to its molecular function, which is not understood. On T cells,TAP appears to be physically independent from the T-cell receptor, yet it can deliver activating signals leading to IL-2 production (ref. 9 and unpublished observations). Recently, we have detected modulation of TAP and associated structures during immune stimulation, consistent with a surface crosslinking event (unpublished observations). In addition, antibody crosslinking of TAP molecules during antigen stimulation of T cells markedly augments the magnitude of response (9) . Thus, it appears that TAP participates in physiologic T-cell activation, during which it, or an associated structure, might conceivably interact with an unknown ligand. Therefore, TAP expression on various resting and activated lymphocytes might influence their activation requirement and cell-cell interaction. In this context, it is intriguing that TAP expression in ontogeny correlates with the acquisition of immunocompetence (10) . Since TAP is observed on both T and B lymphocytes, it is possible that TAP can influence activation occurring through a variety of independent receptors, such as the T-cell receptor or surface immunoglobulin. However, these latter points are speculative. The expression of TAP on resting inducer T cells may reflect unique activation or interaction requirements of these cells. It is also possible that TAP expression on peripheral "resting" inducer T cells reflects activation during thymic maturation that is distinct from that of CTLs and B lymphocytes. Alternatively, some TAP expression could reflect in vivo activation by environmental antigens. These possibilities are not mutually exclusive and need further study.
We have recently demonstrated that the gene controlling TAP expression is tightly linked to the Ly-6 locus (24). However, TAP appears to be molecularly distinct from previously described Ly-6 antigens (24) . The cellular distribution of these Ly-6-linked antigens has not been reported in sufficient detail to allow a precise comparison to TAP, although several of these antigens appear distinct (24, 25) . By use of anti-Ly-6 antisera or mAbs, it has been shown that activated B cells and CTL effectors can express Ly-6 determinants (25, 26, 29) . Given our findings, similar detailed analysis of other Ly-6-linked antigen expression would be of interest. Recent analysis in our laboratory has suggested that one Ly-6-linked antigen, TAPa, may be associated with TAP and coordinately expressed (refs. 9 and 24 and unpublished data).
